Actively Recruiting

Age: 18Years +
All Genders
NCT07231835

Registry of Coronary Disease Outcomes Revascularizing With Drug-Coated Balloons

Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2025-11-17

3000

Participants Needed

1

Research Sites

463 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary aim of this registry is to systematically collect and analyze real-world data on all patients undergoing PCI with the Protégé paclitaxel-eluting DCB to evaluate procedural outcomes, long-term efficacy, and safety across various clinical indications. This registry aims to assess the clinical effectiveness of DCB therapy across diverse patient populations, including those with stable coronary artery disease (CAD) and acute coronary syndromes (ACS), as well as various lesion subsets, encompassing (but not limited to) in-stent restenosis (ISR), de novo coronary lesions, small vessel disease, bifurcation and calcified lesions, coronary bypass graft lesions, and patients at high risk of bleeding. Additionally, the study aims to identify predictors of success, complications, and optimal treatment strategies to further refine the use of DCBs.

CONDITIONS

Official Title

Registry of Coronary Disease Outcomes Revascularizing With Drug-Coated Balloons

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients undergoing PCI with the Protégé paclitaxel-eluting drug-coated balloon
  • Age 18 years or older
  • Presence of a de novo lesion or in-stent restenosis in a native coronary artery or bypass graft suitable for PCI
  • Reference vessel diameter between 2.0 and 4.5 mm
  • Patient suitable for dual antiplatelet therapy (DAPT)
Not Eligible

You will not qualify if you...

  • Unable to provide informed consent
  • Allergy to paclitaxel

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Amsterdam UMC

Amsterdam, Netherlands

Actively Recruiting

Loading map...

Research Team

I

Inge T Bosch

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Registry of Coronary Disease Outcomes Revascularizing With Drug-Coated Balloons | DecenTrialz